These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 12649182

  • 1. Cyclin E expression is a significant predictor of survival in advanced, suboptimally debulked ovarian epithelial cancers: a Gynecologic Oncology Group study.
    Farley J, Smith LM, Darcy KM, Sobel E, O'Connor D, Henderson B, Morrison LE, Birrer MJ, Gynecologic Oncology Group.
    Cancer Res; 2003 Mar 15; 63(6):1235-41. PubMed ID: 12649182
    [Abstract] [Full Text] [Related]

  • 2. Maspin expression in epithelial ovarian cancer and associations with poor prognosis: a Gynecologic Oncology Group study.
    Gynecologic Oncology GroupBox 3079, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC 27710, USA. secor002@mc.duke.edu, Secord AA, Lee PS, Darcy KM, Havrilesky LJ, Grace LA, Marks JR, Berchuck A.
    Gynecol Oncol; 2006 Jun 15; 101(3):390-7. PubMed ID: 16551475
    [Abstract] [Full Text] [Related]

  • 3. Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: a new independent and favorable prognostic marker.
    Yousef GM, Kyriakopoulou LG, Scorilas A, Fracchioli S, Ghiringhello B, Zarghooni M, Chang A, Diamandis M, Giardina G, Hartwick WJ, Richiardi G, Massobrio M, Diamandis EP, Katsaros D.
    Cancer Res; 2001 Nov 01; 61(21):7811-8. PubMed ID: 11691797
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cyclin D1, p53, and p21Waf1/Cip1 expression is predictive of poor clinical outcome in serous epithelial ovarian cancer.
    Bali A, O'Brien PM, Edwards LS, Sutherland RL, Hacker NF, Henshall SM.
    Clin Cancer Res; 2004 Aug 01; 10(15):5168-77. PubMed ID: 15297421
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Co-expression of angiogenic markers and associations with prognosis in advanced epithelial ovarian cancer: a Gynecologic Oncology Group study.
    Secord AA, Darcy KM, Hutson A, Lee PS, Havrilesky LJ, Grace LA, Berchuck A, Gynecologic Oncology Group study.
    Gynecol Oncol; 2007 Jul 01; 106(1):221-32. PubMed ID: 17481705
    [Abstract] [Full Text] [Related]

  • 11. 20q13 and cyclin D1 in ovarian carcinomas. Analysis by fluorescence in situ hybridization.
    Diebold J, Mösinger K, Peiro G, Pannekamp U, Kaltz C, Baretton GB, Meier W, Löhrs U.
    J Pathol; 2000 Apr 01; 190(5):564-71. PubMed ID: 10727982
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. CD44 expression indicates favorable prognosis in epithelial ovarian cancer.
    Sillanpää S, Anttila MA, Voutilainen K, Tammi RH, Tammi MI, Saarikoski SV, Kosma VM.
    Clin Cancer Res; 2003 Nov 01; 9(14):5318-24. PubMed ID: 14614016
    [Abstract] [Full Text] [Related]

  • 14. Cyclin E expression and outcome in pancreatic ductal adenocarcinoma.
    Skalicky DA, Kench JG, Segara D, Coleman MJ, Sutherland RL, Henshall SM, Musgrove EA, Biankin AV.
    Cancer Epidemiol Biomarkers Prev; 2006 Oct 01; 15(10):1941-7. PubMed ID: 17035403
    [Abstract] [Full Text] [Related]

  • 15. The prognostic and predictive value of immunohistochemically detected HER-2/neu overexpression in 361 patients with ovarian cancer: a multicenter study.
    Riener EK, Arnold N, Kommoss F, Lauinger S, Pfisterer J.
    Gynecol Oncol; 2004 Oct 01; 95(1):89-94. PubMed ID: 15385115
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prognostic relevance of cyclin E expression in operable breast cancer.
    Potemski P, Kusińska R, Pasz-Walczak G, Piekarski JH, Watała C, Płuciennik E, Bednarek AK, Kordek R.
    Med Sci Monit; 2009 Feb 01; 15(2):MT34-40. PubMed ID: 19179977
    [Abstract] [Full Text] [Related]

  • 20. HER-2 is an independent prognostic factor in endometrial cancer: association with outcome in a large cohort of surgically staged patients.
    Morrison C, Zanagnolo V, Ramirez N, Cohn DE, Kelbick N, Copeland L, Maxwell GL, Fowler JM.
    J Clin Oncol; 2006 May 20; 24(15):2376-85. PubMed ID: 16710036
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.